358501001: Paracetamol+caffeine 500mg/65mg soluble tablet (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

473183010 Paracetamol+caffeine 500mg/65mg soluble tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1195052011 Paracetamol+caffeine 500mg/65mg soluble tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

473183010 Paracetamol+caffeine 500mg/65mg soluble tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

473183010 Paracetamol+caffeine 500mg/65mg soluble tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

727835017 Paracetamol+caffeine 500mg/65mg soluble tablet (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1195052011 Paracetamol+caffeine 500mg/65mg soluble tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1195052011 Paracetamol+caffeine 500mg/65mg soluble tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Paracetamol+caffeine 500mg/65mg soluble tablet (substance)	Is a	Caffeine- and paracetamol-containing product	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol+caffeine 500mg/65mg soluble tablet (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Non-opioid analgesics	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol+caffeine 500mg/65mg soluble tablet (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Paracetamol	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol+caffeine 500mg/65mg soluble tablet (substance)	Has manufactured dose form	A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition.	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol+caffeine 500mg/65mg soluble tablet (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Phosphodiesterase inhibitor	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol+caffeine 500mg/65mg soluble tablet (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Caffeine	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol+caffeine 500mg/65mg soluble tablet (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Xanthine	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol+caffeine 500mg/65mg soluble tablet (substance)	Has manufactured dose form	Conventional release oral tablet (dose form)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol+caffeine 500mg/65mg soluble tablet (substance)	Is a	Oral caffeine (product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol+caffeine 500mg/65mg soluble tablet (substance)	Is a	Product containing paracetamol in oral dose form (medicinal product form)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol+caffeine 500mg/65mg soluble tablet (substance)	Has manufactured dose form	Soluble tablet	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol+caffeine 500mg/65mg soluble tablet (substance)	Has manufactured dose form	Tablet for oral solution	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol+caffeine 500mg/65mg soluble tablet (substance)	Is a	TEMPORARY parent for CDs that are not updated	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Concept inactivation indicator attribute value reference set (foundation metadata concept)

REPLACED BY association reference set (foundation metadata concept)